McKesson taps Tom Rodgers to lead strategy, business development

McKesson has a new executive in its ranks. Tom Rodgers has been appointed executive vice president and chief strategy and business development officer. He succeeds Bansi Nagji who stepped down from his role effective March 31. 

In his new role, Rodgers will also become a member of the company’s executive operating team. “McKesson has a long history of evolving our company in meaningful ways that enable us to lead in a rapidly changing healthcare environment,” said McKesson CEO Brian Tyler. “Tom’s experience in both venture capital and large healthcare environments, will be extremely valuable to our leadership team as we continue to strengthen our core business and transform our company to create new opportunities to deliver future growth.”

Rodgers will have responsibility for the company’s overall strategic plan and initiatives, as well as key acquisitions and internal programs that drive financial performance, enhance innovation and deliver added value for our customers.

Rodgers currently serves as senior vice president and managing director for McKesson Ventures. He has more than 25 years of experience working in emerging companies, large healthcare environments as well as venture capital firms.

Prior to McKesson Ventures, Rodgers served as director, strategic investments, Cambia Health and was a partner at Advanced Technology Ventures, where he led the fund’s investments in healthcare technology. He previously worked for McKesson from 2001 to 2004 as vice president, corporate strategy and business development. He holds an M.B.A. from the Wharton School and a B.A. from the University of Pennsylvania.

Additionally, Dave Schulte has been named Rodger’s successor to lead McKesson Ventures, McKesson’s strategic venture capital firm that focuses on investing in innovative approaches to address business challenges facing the healthcare industry.

Schulte joined McKesson in 2015 and has most recently served as managing director for McKesson Ventures. He has more than 20 years of experience as an investor and investment banker, partnering with entrepreneurs to build innovative healthcare and technology businesses. Prior to joining McKesson, Schulte ran Kaiser Permanente Ventures where he helped to build the investment program from $20 million to $400 million of assets under management. He is a graduate of St. John's University and earned a Master of Public Policy degree from Harvard University